Art

J-GLOBAL ID：201902207709371072   Reference number：19S0464471

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

Author (14)： Eto, Masatoshi (Kumamoto University, Department of Urology, Faculty of Life Sciences) ,  Kawano, Yoshiaki (Kumamoto University, Department of Urology, Faculty of Life Sciences) ,  Hirao, Yoshihiko (Nara Medical University, Department of Urology) ,  Mita, Koji (Department of Urology, Hiroshima City Asa Hospital) ,  Arai, Yoichi (Tohoku University Graduate School of Medicine, Department of Urology) ,  Tsukamoto, Taiji (Sapporo Medical University, Department of Urology) ,  Hashine, Katsuyoshi (Department of Urology, National Hospital Organization Shikoku Cancer Center) ,  Matsubara, Akio (Institute of Biomedical and Health Sciences, Hiroshima University, Department of Urology) ,  Fujioka, Tomoaki (Iwate Medical University School of Medicine, Department of Urology) ,  Kimura, Go (Department of Urology, Nippon Medical School) ,  Shinohara, Nobuo (Hokkaido University Graduate School of Medicine, Department of Urology) ,  Tatsugami, Katsunori (Kyushu University, Department of Urology, Graduate School of Medical Sciences) ,  Naito, Seiji (Kyushu University, Department of Urology, Graduate School of Medical Sciences) ,  Hinotsu, Shiro (Kyoto University, Department of Phamacoepidemiology, Graduate School of Medicine and Public Health)
Material： BMC Cancer
Volume： 15  Issue： 1  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 1471-2407  CODEN： BCMAC 
Country of issue： United Kingdom (GBR)  Language： English (EN)